References

References

American Thoracic Society; Infectious Diseases Society of America (2005) Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 171: 388–416

Bauer TT, Ferrer R, Angrill J et al. (2000) Ventilator-associated pneumonia: incidence, risk factors, and microbiology. Seminars in Respiratory Infections 15: 272–79

Bouza E, Hortal J, Munoz P et al. (2006) Post-operative infections after major heart surgery and prevention of ventilator-associated pneumonia: a one day European prevalence study (ESGNI-008). Journal of Hospital Infection 64: 230–4

Carter J, Hodd J, Young P (2009) The PneuX P.Y. tracheal tube: cost effectiveness in the general intensive care unit. Critical Care Medicine 37: A466

Crommett J, Dinh A, Chang E et al. (2012) Mass of luminal secretion: comparison between PneuX and PVC tracheal tubes. Critical Care Medicine 40: U285

Dodek P, Keenan S, Cook D et al. (2004) Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Annals of Internal Medicine 141: 305–13

Doyle A, Fletcher A, Carter J et al. (2011) The incidence of ventilator-associated pneumonia using the PneuX System with or without elective endotracheal tube exchange: a pilot study. BMC Research Notes 4: 92

Fletcher A, Carter J, Blunt M et al. (2009) Incidence of ventilator-associated pneumonia in patients undergoing elective tube exchange to LoTrach endotracheal tubes. Critical Care 13: S122

Gopal S, Luckraz H, Giri R et al. (2015) Significant reduction in ventilator-associated pneumonia with the Venner-PneuX System in high-risk patients undergoing cardiac surgery: the Low Ventilator-Associated-Pneumonia study. European Journal of Cardio-Thoracic Surgery 47: e92–6

Gopal S, Luckraz H, Giri Ret al. (2013) Benefits of the Venner PneuX endotracheal tube in high-risk patients undergoing cardiac surgery. Critical Care Medicine 41: A274

Health and Social Care Information Centre (2015) Adult Critical Care Data in England – April 2013 to March 2014. [online; accessed 01 October 2015]

Hodd J, Doyle A, Irvine M et al. (2009) Preventing unplanned extubation with the Pneux P.Y. System (LoTrach) – An engineered solution. Critical Care Medicine 37: A192

Hunter JD (2012) Ventilator associated pneumonia. British Medical Journal 344: e3325

Kollef MH (1999) The prevention of ventilator-associated pneumonia. The New England Journal of Medicine 340: 627–34

Masterton RG, Galloway A, French G et al. (2008) Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy 62: 5–34

Safdar N, Dezfulian C, Collard HR et al. (2005) Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Critical Care Medicine 33: 2184–93

Smith N, Khan F, Gratrix A (2014) A retrospective review of patients managed with the Pneux PY VAP prevention system. Journal of the Intensive Care Society 15(2): 99–103

Smith N, Khan F, Gratrix A (2011) The PneuX pneumonia prevention system and the incidence of ventilator associated pneumonia. Intensive Care Medicine 37: S276

Zuschneid I, Schwab F, Geffers C et al. (2007) Trends in ventilator-associated pneumonia rates within the German nosocomial infection surveillance system (KISS). Infection Control and Hospital Epidemiology 28: 314–8